Urovant Sciences & Sunovion Pharmaceuticals Launch Promotion of GEMTESA For Overactive Bladder Patients
In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read moreIn full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read moreMARLBOROUGH – Urovant Sciences yesterday, June 18, announced it has entered into an exclusive 3-year distribution agreement with Sunovion Pharmaceuticals
Read more